Atrial Fibrillation Trial, Recruiting NCT07064616 Sponsor: Kitasato University Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT07064616
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 18 and 85 years of age
  • People who have been diagnosed with persistent atrial fibrillation (an irregular heart rhythm that has lasted less than one year, or that has needed a procedure to restore normal rhythm)
  • People whose condition meets the current Japanese medical guidelines for a heart procedure called catheter ablation (a treatment that uses energy to correct abnormal heart signals)
  • People who have signed a written consent form agreeing to take part in the trial

Who may not be able to join:

  • People whose atrial fibrillation is the short-term, comes-and-goes type (called paroxysmal AF), or has been ongoing for more than one year (called long-standing persistent AF)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +81-778-8111

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Kitasato University
Registry
ClinicalTrials.gov
Start date
25 June 2025
Est. completion
31 December 2027

Where this trial is recruiting

🇯🇵 Japan

Primary endpoints

Freedom from atrial fibrillation recurrence at 12 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov